View of A Comparative Safety and Efficacy Study of Olmesrtan, a Newer Angiotensin-II Type-1 Receptor Blocker in Early Stage Type–2 Diabetes with Hypertension

Return to Article Details A Comparative Safety and Efficacy Study of Olmesrtan, a Newer Angiotensin-II Type-1 Receptor Blocker in Early Stage Type–2 Diabetes with Hypertension Download Download PDF